FIELD: pharmaceutics.
SUBSTANCE: invention refers to pharmaceutical industry and represents a anti-osteoporotic agent containing trace elements in the form of borate and manganese salt and vitamin D3, characterised by additional introduction of natural conformers of amber or fumaric acid in the form of acid and ammonium salts of calcium, magnesium and zinc in aqua-chelate form, microelements in the form of fluoride and selenate as sodium or potassium salts, calcium caseinate enriched with glycine and mono-L-glutamate sodium; at that, components of the agent are taken in certain proportions, mg/dose.
EFFECT: invention provides for expansion of the range of medications for treatment of osteoporosis, improvement of therapeutic effect, as well as elimination of side effects and recurrences.
6 cl, 4 dwg, 3 tbl
